Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05821075
PHASE1/PHASE2

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Sponsor: October 6 University

View on ClinicalTrials.gov

Summary

Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy

Official title: Comparative Study Between Prednisolone, Cerebrolysin in the Treatment of Bell's Palsy

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2023-08-24

Completion Date

2026-02

Last Updated

2025-07-31

Healthy Volunteers

No

Conditions

Interventions

DRUG

Prednisolone

prednisolone 60mg tablet once daily for 5 days then tapering dose

DRUG

Cerebrolysin

intramuscular Cerebrolysin 10 mg daily for 3 weeks

Locations (1)

October 6 university hospital

Giza, Egypt